sale yoy pf came our/street pf
estim beat evenli distribut /csi growth
continu led daili silicon hydrogel stronger expect growth
paragard drove csi non-gaap ep came our/street
estim primarili owe fx wors forecast also
highlight focu acceler spend advertising/promot activ key
account drive new wearer growth well expand invest paraguard
manag note stronger contact len market vs histor growth rate
wearer continu trade daili forma sale guidanc rais
slightli report sales/ep lower reduc fx tailwind
coopervis grew pro forma growth continu driven
silicon hydrogel sihi particular daili clariti myday sihi grew solid
pf strength broad-bas geograph asiapac acceler
vs emea improv vs america grew
vs myday toric roll-out continu strong
account initi enabl sauflon acquisit expand
daili portfolio greater capac focus drive new wearer
growth key account global retail region chains/buy group focu
increas sales/advertising/promot invest convert/dr new wearer
growth up-front cost higher manag point sticki
custom return invest
surgic sale grew pro forma driven stronger expect paragard
fertil growth fertil solut off-set weak
genom devot resourc transit away carrier screening/
nipt focu fulli ivf clinic increas invest sales/
advertis paragard expect mid-singl digit growth look ahead
guidanc sale guidanc rais slightli pro forma basi
low end growth yoy yoy previous csi growth
flat previous anticip fx benefit revenu
lower given recent movement ep guidanc lower
previous wors fx
estim lower sale estim slightli ep estim
primarili fx forecast sale
ep tax rate fx headwind report
growth pt bump recent peer multipl expans
off-set lower estim
cooper compani global
medic devic compani focus
primarili
develop
market soft contact lens
compani also market varieti
surgic instrument
analyst certif import disclosur see disclosur
grow ahead market constant
oper margin y/i led contribut
paragard acquisit fx tailwind
len market grow next five year
paragard
better expect margin expans
channel
target price estim cash ep
competit stiffen contact len market
estim above-market contact len growth driven
compani specialti len offer silicon hydrogel
daili rollout forecast mid-singl digit sale growth
recent acquir paragard iud rate share perform
valuat
competit dynam toughen
price target impli approxim multipl cash ep line peer group current-year multipl
risk includ single-us market growth stall competit increas emerg market revenu meaning
cooper compani quarterli incom statement million
non single-us sphere
amort intang
